CannRx (wholly owned subsidiary)
Developing high-quality pharmaceutical and analytical products utilizing the cannabis plant by leveraging the patented technology and established botanical expertise of Izun.
Filed six patents for a unique delivery system for cannabinoid compositions that can effectively capture and deliver all active components of the marijuana plant.
Initial focus on two therapeutic areas – Sleep disorders and Pain.
Intend to initiate clinical trials Q2 2018.
For more information, check out the CannRx Technologies Inc. website.